Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels

Chemoresistance is a major problem in the therapeutic management of pancreatic cancer, concurring to poor clinical outcome. A number of mechanisms have been proposed to explain resistance to gemcitabine, a standard of care for this malignancy, among which is included aberrant miRNA expression. In th...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Biomolecules
Main Authors: Panebianco, Concetta, Trivieri, Nadia, Villani, Annacandida, Terracciano, Fulvia, Latiano, Tiziana Pia, Potenza, Adele, Perri, Francesco, Binda, Elena, Pazienza, Valerio
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8146031/
https://ncbi.nlm.nih.gov/pubmed/33925948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom11050639
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki